Horizon Therapeutics

Horizon Therapeutics Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Horizon Therapeutics key operating metrics including Pre-Clinical Phase Products, environmental, and social and governance score (ESG).

Pre-Clinical Phase Products

33.3%

Sep, 2021

Products

10.0%

FY, 2020

Phase 3b/4 Trials Products

50.0%

FY, 2019

Operating Metrics

Metrics	FY, 2018	FY, 2019	FY, 2020
Pre-Clinical Phase Products	3	3
Products	11	10	11
Phase 3b/4 Trials Products	2	3
Phase III Trials Products	2	1
Phase I Trials Products		1

40-49 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub